Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02048371
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:29.416372+00:00
Published At
2023-11-07T00:00:00+00:00
Record Updated At
2023-11-07
Results Posted At
2023-11-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Liposarcoma", "Osteogenic Sarcoma", "Ewing/Ewing-like Sarcoma", "Rhabdomyosarcoma", "Mesenchymal Chondrosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-07"
protocolSection.identificationModule.nctId
"NCT02048371"
protocolSection.identificationModule.officialTitle
"SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-11-07"

Study condition terms

  • Liposarcoma (protocolSection.conditionsModule.conditions)
  • Osteogenic Sarcoma (protocolSection.conditionsModule.conditions)
  • Ewing/Ewing-like Sarcoma (protocolSection.conditionsModule.conditions)
  • Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Mesenchymal Chondrosarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.